bucladesine has been researched along with acebutolol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chao, J; Weathersbee, CJ | 1 |
Barbry, P; Besmond, C; Kahn, A; Marie, J; Munnich, A; Pichard, AL; Reach, G; Simon, MP; Vaulont, S | 1 |
3 other study(ies) available for bucladesine and acebutolol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Regulation of maltodextrin phosphorylase synthesis in Escherichia coli by cyclic adenosine 3', 5'-monophosphate and glucose.
Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Bucladesine; Carbon Radioisotopes; Cell-Free System; Cyclic AMP; Enzyme Induction; Enzyme Repression; Escherichia coli; Glucose; Glucosyltransferases; Maltose; Membrane Transport Proteins; Phosphorylases; Rifampin; RNA, Messenger; Transcription, Genetic | 1974 |
Cyclic AMP as a transcriptional inhibitor of upper eukaryotic gene transcription.
Topics: Animals; Bucladesine; Cyclic AMP; Dietary Carbohydrates; DNA; Glucagon; Glycolysis; Liver; Maltose; Pyruvate Kinase; Rats; RNA, Messenger; Time Factors; Transcription, Genetic | 1984 |